Itau Unibanco Holding S.A. Syndax Pharmaceuticals Inc Transaction History

Itau Unibanco Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$7.47 - $10.76 $10,629 - $15,311	-1,423 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$4.9 - $9.31 $5,904 - $11,218	-1,205 Reduced 45.85%	1,423 $13,000
Q4 2018 Feb 13, 2019	BUY	$3.6 - $8.42 $864 - $2,020	240 Added 10.05%	2,628 $11,000
Q3 2018 Nov 13, 2018	SELL	$6.33 - $8.08 $5,494 - $7,013	-868 Reduced 26.66%	2,388 $19,000
Q2 2018 Aug 13, 2018	SELL	$6.93 - $14.63 $173 - $365	-25 Reduced 0.76%	3,256 $23,000
Q1 2018 May 14, 2018	BUY	$8.71 - $14.82 $20,285 - $34,515	2,329 Added 244.64%	3,281 $47,000
Q4 2017 Feb 09, 2018	BUY	$7.8 - $12.94 $1,591 - $2,639	204 Added 27.27%	952 $8,000
Q3 2017 Nov 14, 2017	BUY	$10.9 - $12.73 $8,153 - $9,522	748	748 $28,000

232

96.9M

1.39M

543K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $927M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.